BIG by Matt Stoller • 32086 implied HN points • 03 Feb 24
- Dialysis industry is controlled by two powerful corporations - DaVita and Fresenius - impacting over half a million lives. Non-compete agreements could potentially change this monopoly.
- Dialysis is a critical treatment provided under universal healthcare for end-stage renal disease patients, but monopolistic control has led to issues like patient coercion and quality concerns.
- The lack of competition and consolidation in the dialysis market has led to lower survival rates in the US compared to other countries. Eliminating non-compete agreements for healthcare professionals could foster innovation and improve patient care.